Correlation Between Viridian Therapeutics and Ideaya Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Ideaya Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Ideaya Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Ideaya Biosciences, you can compare the effects of market volatilities on Viridian Therapeutics and Ideaya Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Ideaya Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Ideaya Biosciences.

Diversification Opportunities for Viridian Therapeutics and Ideaya Biosciences

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Viridian and Ideaya is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Ideaya Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ideaya Biosciences and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Ideaya Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ideaya Biosciences has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Ideaya Biosciences go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Ideaya Biosciences

Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 1.12 times more return on investment than Ideaya Biosciences. However, Viridian Therapeutics is 1.12 times more volatile than Ideaya Biosciences. It trades about 0.16 of its potential returns per unit of risk. Ideaya Biosciences is currently generating about 0.1 per unit of risk. If you would invest  1,397  in Viridian Therapeutics on June 2, 2025 and sell it today you would earn a total of  441.00  from holding Viridian Therapeutics or generate 31.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Viridian Therapeutics  vs.  Ideaya Biosciences

 Performance 
       Timeline  
Viridian Therapeutics 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Viridian Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Viridian Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Ideaya Biosciences 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Ideaya Biosciences are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ideaya Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Viridian Therapeutics and Ideaya Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viridian Therapeutics and Ideaya Biosciences

The main advantage of trading using opposite Viridian Therapeutics and Ideaya Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Ideaya Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ideaya Biosciences will offset losses from the drop in Ideaya Biosciences' long position.
The idea behind Viridian Therapeutics and Ideaya Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stocks Directory
Find actively traded stocks across global markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes